Science Explorer Back to mapMap
Discussion
Company · San Jose · United States

Aridis Pharmaceuticals (United States)

Research works
34
▲ 37% vs 2018-21
Citations
2k
58.6 per fractional work
Top-10% rate
20.6%
all institutions 10.0%
Open access
45%
world 40%
International
21%
world 18%

Not ranked overall: Aridis Pharmaceuticals (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Aridis Pharmaceuticals (United States) work in?

In all years, 37% of research at Aridis Pharmaceuticals (United States) is in Life Sciences, 32% in Health Sciences. Its largest fields are Medicine (29%), Biochemistry, Genetics and Molecular Biology (24%), Social Sciences (9%). It does 1.9× the world's share of Life Sciences.

Life Sciences: 13 fractional works · 37.0% of its workBiochemistry, Genetics and Molecular Biology: 8 fractional works · 23.7% of its workMolecular Biology: 7 fractional works · 19.1% of its workMolecular Medicine: 1 fractional works · 1.9% of its workEndocrinology: 0 fractional works · 1.1% of its workBiochemistry: 0 fractional works · 0.5% of its workBiotechnology: 0 fractional works · 0.5% of its workGenetics: 0 fractional works · 0.5% of its workImmunology and Microbiology: 2 fractional works · 4.6% of its workImmunology: 1 fractional works · 2.7% of its workMicrobiology: 1 fractional works · 2.0% of its workPharmacology, Toxicology and Pharmaceutics: 2 fractional works · 4.6% of its workPharmacology: 1 fractional works · 2.1% of its workPharmaceutical Science: 1 fractional works · 2.0% of its workToxicology: 0 fractional works · 0.5% of its workAgricultural and Biological Sciences: 1 fractional works · 4.1% of its workPlant Science: 1 fractional works · 2.9% of its workFood Science: 0 fractional works · 0.6% of its workAnimal Science and Zoology: 0 fractional works · 0.5% of its workHealth Sciences: 11 fractional works · 31.7% of its workMedicine: 10 fractional works · 29.0% of its workInfectious Diseases: 2 fractional works · 5.1% of its workPulmonary and Respiratory Medicine: 2 fractional works · 4.7% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 4.1% of its workOncology: 1 fractional works · 2.9% of its workSurgery: 1 fractional works · 1.9% of its workEpidemiology: 1 fractional works · 1.8% of its workImmunology and Allergy: 1 fractional works · 1.8% of its workRheumatology: 0 fractional works · 1.3% of its workEmergency Medicine: 0 fractional works · 0.8% of its workPhysiology: 0 fractional works · 0.6% of its workHematology: 0 fractional works · 0.6% of its workGenetics: 0 fractional works · 0.5% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.5% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.5% of its workPharmacology: 0 fractional works · 0.5% of its workDermatology: 0 fractional works · 0.3% of its workComplementary and alternative medicine: 0 fractional works · 0.2% of its workFamily Practice: 0 fractional works · 0.2% of its workNephrology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.6% of its workHealth Professions: 0 fractional works · 1.5% of its workSpeech and Hearing: 0 fractional works · 1.0% of its workMedical Laboratory Technology: 0 fractional works · 0.5% of its workDentistry: 0 fractional works · 1.0% of its workOral Surgery: 0 fractional works · 1.0% of its workNursing: 0 fractional works · 0.2% of its workNutrition and Dietetics: 0 fractional works · 0.2% of its workSocial Sciences: 6 fractional works · 16.6% of its workSocial Sciences: 3 fractional works · 8.6% of its workSociology and Political Science: 2 fractional works · 4.4% of its workAnthropology: 1 fractional works · 1.6% of its workCultural Studies: 0 fractional works · 1.3% of its workEducation: 0 fractional works · 1.0% of its workSafety Research: 0 fractional works · 0.3% of its workPsychology: 1 fractional works · 3.3% of its workClinical Psychology: 1 fractional works · 2.9% of its workExperimental and Cognitive Psychology: 0 fractional works · 0.3% of its workBusiness, Management and Accounting: 1 fractional works · 2.9% of its workManagement Information Systems: 1 fractional works · 2.9% of its workArts and Humanities: 0 fractional works · 1.3% of its workPhilosophy: 0 fractional works · 1.3% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.5% of its workEconomics and Econometrics: 0 fractional works · 0.5% of its workPhysical Sciences: 5 fractional works · 14.7% of its workChemistry: 2 fractional works · 5.2% of its workOrganic Chemistry: 1 fractional works · 3.8% of its workSpectroscopy: 0 fractional works · 1.0% of its workAnalytical Chemistry: 0 fractional works · 0.5% of its workEarth and Planetary Sciences: 1 fractional works · 2.3% of its workGeophysics: 1 fractional works · 2.0% of its workPaleontology: 0 fractional works · 0.3% of its workEngineering: 1 fractional works · 2.0% of its workMechanical Engineering: 0 fractional works · 1.0% of its workBiomedical Engineering: 0 fractional works · 0.6% of its workElectrical and Electronic Engineering: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.0% of its workComputer Science: 1 fractional works · 2.0% of its workArtificial Intelligence: 0 fractional works · 0.6% of its workComputer Networks and Communications: 0 fractional works · 0.5% of its workComputer Vision and Pattern Recognition: 0 fractional works · 0.5% of its workInformation Systems: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEnvironmental Science: 1 fractional works · 1.8% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 1.5% of its workEcology: 0 fractional works · 0.3% of its workMaterials Science: 0 fractional works · 1.0% of its workMaterials Chemistry: 0 fractional works · 1.0% of its workMathematics: 0 fractional works · 0.5% of its workModeling and Simulation: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workALL ITS WORKAridisPharmaceuticals…34fractional works, all years
Life Sciences37%Physical Sciences15%Health Sciences32%Social Sciences17%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 20 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology823.7%
    2. Immunology and Microbiology24.6%
    3. Pharmacology, Toxicology and Pharmaceutics24.6%
    4. Agricultural and Biological Sciences14.1%
    1. Medicine1029.0%
    2. Health Professions01.5%
    3. Dentistry01.0%
    4. Nursing00.2%
    1. Social Sciences38.6%
    2. Psychology13.3%
    3. Business, Management and Accounting12.9%
    4. Arts and Humanities01.3%
    5. Economics, Econometrics and Finance00.5%
    1. Chemistry25.2%
    2. Earth and Planetary Sciences12.3%
    3. Engineering12.0%
    4. Computer Science12.0%
    5. Environmental Science11.8%
    6. Materials Science01.0%
    7. Mathematics00.5%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 2.23× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.92× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 2.72× its world share, 0 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 6.63× its world share, 0 worksPharmacology, Toxico…Chemistry: 1.40× its world share, 0 worksChemistryComputer Science: 0.42× its world share, 0 worksComputer ScienceEngineering: 0.29× its world share, 0 worksEngineeringMedicine: 1.75× its world share, 3 worksMedicineArts and Humanities: 0.51× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 4.08× its world share, 1 worksBusiness, Management…Psychology: 0.48× its world share, 0 worksPsychologySocial Sciences: 1.15× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 6.6×. Every wedge is a field page.

All 12 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics6.63×0 works
  2. Business, Management and Accounting4.08×1 works
  3. Immunology and Microbiology2.72×0 works
  4. Agricultural and Biological Sciences2.23×1 works
  5. Biochemistry, Genetics and Molecular Biology1.92×1 works
  6. Medicine1.75×3 works
  7. Chemistry1.40×0 works
  8. Social Sciences1.15×1 works
  9. Arts and Humanities0.51×0 works
  10. Psychology0.48×0 works
  11. Computer Science0.42×0 works
  12. Engineering0.29×0 works

Who are the top researchers at Aridis Pharmaceuticals (United States)?

Ranked on the quality score, Vu L. Truong-Le, Vu Truong and Karen Hainsworth lead among researchers whose main affiliation is Aridis Pharmaceuticals (United States).

  1. 1 Vu L. Truong-Le United States · #523,675 worldwide 1.9k citations · 19 works
  2. 2 Vu Truong United States · #2,638,351 worldwide 191 citations · 29 works
  3. 3 Karen Hainsworth United States · #4,058,004 worldwide 27 citations · 16 works
All ranked researchers at Aridis Pharmaceuticals (United States)

What are the most cited papers from Aridis Pharmaceuticals (United States)?

The most cited paper from Aridis Pharmaceuticals (United States) is "Catastrophic Antiphospholipid Syndrome: Clinical and Laboratory Features of 50 Patients" (Ronald A. Asherson, Ricard Cervera, Jean‐Charles Piette et al., 1998), with 549 citations. Next come "Trehalose: Current Use and Future Applications" (493) and "Interactions of formulation excipients with proteins in solution and in the dried state" (398).

Most cited papers
#PaperReleasedCitations
1 Catastrophic Antiphospholipid Syndrome: Clinical and Laboratory Features of 50 Patients Ronald A. Asherson, Ricard Cervera, Jean‐Charles Piette et al. · Medicine May 1998 549
2 Trehalose: Current Use and Future Applications Satoshi Ohtake, Y. John Wang · Journal of Pharmaceutical Sciences 18 Feb 2011 493
3 Interactions of formulation excipients with proteins in solution and in the dried state Satoshi Ohtake, Yoshiko A. Kita, Tsutomu Arakawa · Advanced Drug Delivery Reviews Review 13 Jul 2011 398
4 Controlled Dimerization of ErbB Receptors Provides Evidence for Differential Signaling by Homo- and Heterodimers Senthil K. Muthuswamy, Michael Gilman, Joan S. Brugge · Molecular and Cellular Biology Open access Oct 1999 367
5 Platelet-Derived Growth Factor Induces Phosphorylation of Multiple JAK Family Kinases and STAT Proteins Marie‐Luce Vignais, Henry B. Sadowski, Diane Watling et al. · Molecular and Cellular Biology Open access Apr 1996 249
All 67 most cited papers, with filters and sorting

Which keywords describe research at Aridis Pharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Nanoparticles, Glycosylation, Epidemiology, Antibiotic Resistance, Cancer Therapy, Monoclonal Antibodies, Therapeutic Antibodies and Vaccine.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 29 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 29 words, with their numbers
  1. Epidemiology3▲ 2.2×17 topics
  2. Nanoparticles2▲ 5.0×5 topics
  3. Cancer2▲ 3.7×7 topics
  4. Glycosylation2▲ 22×2 topics
  5. Inflammation2▲ 2.2×11 topics
  6. Cancer Therapy2▲ 6.9×3 topics
  7. Antibiotic Resistance1▲ 10×3 topics
  8. Monoclonal Antibodies1▲ 28×2 topics
  9. Pathogenesis1▲ 7.4×8 topics
  10. Therapeutic Antibodies1▲ 32×2 topics
  11. Vaccine1▲ 10×5 topics
  12. Anticancer Agents1▲ 15×4 topics
  13. Mutation1▲ 24×3 topics
  14. Transcriptional Regulation1▲ 15×2 topics
  15. Antibody Engineering1▲ 33×1 topic
  16. Big Data1▲ 6.0×2 topics
  17. Ethics1▲ 7.1×3 topics
  18. Fc Receptors1▲ 33×1 topic
  19. Supply Chain Management1▲ 6.3×2 topics
  20. Analytics1▲ 55×1 topic
  21. Business Intelligence1▲ 55×1 topic
  22. Clinical Practice Guidelines1▲ 5.3×3 topics
  23. Developmental Trauma1▲ 93×1 topic
  24. Immunity1▲ 8.8×5 topics
  25. Inhaler Devices1▲ 97×1 topic
  26. Philosophy1▲ 6.6×2 topics
  27. Psychodynamic Psychotherapy1▲ 93×1 topic
  28. Pulmonary Drug Delivery1▲ 97×1 topic
  29. Sociology1▲ 22×2 topics

Which research topics does Aridis Pharmaceuticals (United States) publish most on?

By volume in 2022-now: Big Data and Business Intelligence, Viral Infectious Diseases and Gene Expression in Insects, Food Allergy and Anaphylaxis Research and Smart Agriculture and AI.

  1. 1 Big Data and Business Intelligence Management Information Systems 1 works
  2. 2 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 0 works
  3. 3 Food Allergy and Anaphylaxis Research Immunology and Allergy 0 works
  4. 4 Smart Agriculture and AI Plant Science 0 works
  5. 5 Citizenship Education and Democracy Education 0 works
  6. 6 Health, Education, and Cultural Studies Sociology and Political Science 0 works
  7. 7 Berry genetics and cultivation research Plant Science 0 works
  8. 8 Tree Root and Stability Studies Mechanical Engineering 0 works
  9. 9 Religious and Theological Studies Sociology and Political Science 0 works
  10. 10 Respiratory and Cough-Related Research Pulmonary and Respiratory Medicine 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available44.7%not open55.3%

World: 40% of research is openly available.

with international co-authors20.8%domestic only79.2%

World: 18% is written across borders.

How has Aridis Pharmaceuticals (United States)'s research output changed?

Output in 2022-2025 was 37% higher than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Aridis Pharmaceuticals (United States) as a percentage of every work published that year, 0.000020% in 2024.

still counting0.00010%0.00020%Aridis Pharmaceuticals (United States)0.000018% in 2025200020102020

Fractional works of Aridis Pharmaceuticals (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in San Jose

All research institutions in San Jose

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Aridis Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.